Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Prospective Randomized Study of Elective Regional Lymph Node Irradiation in Pathologic N1 Breast Cancer Patients Treated With Breast Conserving Surgery

NCT03269981 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03269981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03269981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Prospective Randomized Study of Elective Regional Lymph Node Irradiation in Pathologic N1 Breast Cancer Patients Treated With Breast Conserving Surgery
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 1, 2017
Completion date
December 30, 2029
Enrollment
827 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm